参考文献/References:
[1] Eckert MJ,Martin MJ.Trauma:Spinal cord injury[J].Surg Clin North Am,2017,97(5):1031-1045.
[2] Kjell J,Olson L.Rat models of spinal cord injury:From pathology to potential therapies[J].Dis Model Mech,2016,9(10):1125-1137.
[3] Orr MB,Gensel JC.Spinal cord injury scarring and inflammation:Therapies targeting glial and inflammatory responses[J].Neurotherapeutics,2018,15(3):541-553.
[4] Bloom O,Herman PE,Spungen AM.Systemic inflammation in traumatic spinal cord injury[J].Exp Neurol,2020,325:113-143.
[5] 崔 佳,刘敏丽.乙酰左旋肉碱对脊髓损伤后线粒体的保护作用研究进展[J].陕西医学杂志,2021,50(3):374-376.
[6] Fan B,Wei Z,Yao X,et al.Microenvironment imbalance of spinal cord injury[J].Cell Transplant,2018,27(6):853-866.
[7] 黄 珊,宁佐伟,王国正,等.脂多糖通过NOD样受体蛋白3炎症小体通路诱导大鼠急性肝损伤实验研究[J].陕西医学杂志,2021,50(3):264-267,271.
[8] Noel P,Von Hoff DD,Saluja AK,et al.Triptolide and its derivatives as cancer therapies[J].Trends Pharmacol Sci,2019,40(5):327-341.
[9] Xu H,Liu B.Triptolide-targeted delivery methods[J].Eur J Med Chem,2019,164:342-351.
[10] Wei YM,Wang YH,Xue HQ,et al.Triptolide,a potential autophagy modulator[J].Chin J Integr Med,2019,25(3):233-240.
[11] Karaoz E,Tepekoy F,Yilmaz I,et al.Reduction of inflammation and enhancement of motility after pancreatic islet derived stem cell transplantation following spinal cord injury[J].J Korean Neurosurg Soc,2019,62(2):153-165.
[12] Cofano F,Boido M,Monticelli M,et al.Mesenchymal stem cells for spinal cord injury:Current options,limitations,and future of cell therapy[J].Int J Mol Sci,2019,20(11):2698.
[13] Hou ZY,Tong XP,Peng YB,et al.Broad targeting of triptolide to resistance and sensitization for cancer therapy[J].Biomed Pharmacother,2018,104:771-780.
[14] 李一帆,陈 东,张大威,等.急性大鼠脊髓损伤Allen's法模型的改良及电生理评价[J].中国实验诊断学,2010,14(8):1169-1172.
[15] 张海滨.小鼠脊髓损伤模型的建立及神经干细胞移植后运动功能恢复情况的研究[D].太原:山西医科大学,2014.
[16] Zuo G,Ren X,Qian X,et al.Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy[J].J Cell Physiol,2019,234(2):1925-1936.
[17] Yang ZH,Lu YJ,Gu KP,et al.Effect of ulinastatin on myocardial ischemia-reperfusion injury through JNK and P38 MAPK signaling pathways[J].Eur Rev Med Pharmacol Sci,2019,23(19):8658-8664.
[18] Kuprash DV,Nedospasov SA.Molecular and cellular mechanisms of inflammation[J].Biochemistry(Mosc),2016,81(11):1237-1239.
[19] Jo EK,Kim JK,Shin DM,et al.Molecular mechanisms regulating NLRP3 inflammasome activation[J].Cell Mol Immunol,2016,13(2):148-159.
[20] Zhong Z,Sanchez-Lopez E,Karin M.Autophagy,NLRP3 inflammasome and auto-inflammatory/immune diseases[J].Clin Exp Rheumatol,2016,34:12-16.
[21] Shao BZ,Wang SL,Pan P,et al.Targeting NLRP3 inflammasome in inflammatory bowel disease:Putting out the fire of inflammation[J].Inflammation,2019,42(4):1147-1159.
相似文献/References:
[1]高 峰,王秀会,夏胜利,等.雷公藤甲素对人骨肉瘤细胞阿霉素耐药株的逆转作用及机制研究[J].陕西医学杂志,2021,50(6):648.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.002]
GAO Feng,WANG Xiuhui,XIA Shengli,et al.Reversal effect and mechanism of triptolide on adriamycin-resistant human osteosarcoma cell line[J].,2021,50(6):648.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.002]
[2]梁朝鑫,周安远,王 伟,等.骨髓间充质干细胞治疗骨科疾病研究进展[J].陕西医学杂志,2022,51(1):121.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.030]
LIANG Chaoxin,ZHOU Anyuan,WANG Wei,et al.Research progress of bone marrow mesenchymal stem cells in the treatment of orthopedic diseases[J].,2022,51(6):121.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.030]
[3]周立新,孙忠人,尹洪娜.热休克蛋白70促进脊髓损伤恢复研究进展[J].陕西医学杂志,2023,52(10):1434.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.035]
ZHOU Lixin,SUN Zhongren,YIN Hongna.Research progress of Hsp70 promoting spinal cord injury recovery[J].,2023,52(6):1434.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.035]